ISO/TS 16766:2024

Current Revision
Manufacturers’ considerations for in vitro diagnostic medical devices in a public health emergency

Best Price Guarantee Jan 1, 2024 English 20 Pages

Sub Total (1 Item(s)) $ 0.00
Estimated Shipping $ 0.00
Total (Pre-Tax) $ 0.00

You own the digital copy of this edition

View in Library
or
International Organization for Standardization Logo

ISO/TS 16766:2024

Manufacturers’ considerations for in vitro diagnostic medical devices in a public health emergency

PUBLISH DATE 2024
ISO/TS 16766:2024

This document provides guidance to manufacturers on the minimum requirements for the lifecycle management of in vitro diagnostic (IVD) medical devices that are developed in preparation for and in response to a public health emergency involving infectious agents requiring immediate availability of authorized IVD devices.

NOTE This document does not replace existing national (or regional) regulatory pathway requirements for IVD medical devices under non-emergency situations. The regulatory authorization process of emergency use-IVD medical devices is country-specific and it includes:

  • following a risk management process;
  • monitoring the device’s post-market performance and quality assurance;
  • implementing a communication system.
Loading...

Failed to load document history.

Publish Date Document Id Type View